Interaction of GLP-I and leptin at rat pancreatic B-cells: Effects on insulin secretion and signal transduction

Hormone and Metabolic Research

Volumn 29, Issue 11, 1997, Pages 572-576

  Fehmann, H C ^a   Bode, H P ^a   Ebert, T ^a   Karl, A ^a   Goke B ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

GLP I; Glucagon like Peptide I; Incretin Effect; Insulin; Leptin; Leptin Receptor

Indexed keywords

CALCIUM; CYCLIC AMP; FORSKOLIN; GLUCAGON LIKE PEPTIDE 1; INSULIN; LEPTIN; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; INSULIN RELEASE; INSULINOMA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALIA;

EID: 0031435277     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979103     Document Type: Article

References (37)

1. Perley, M. J., D. M. Kipnis: Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects. J. Clin. Invest. 46: 1954-1962 (1967)
2. Creutzfeldt, W.: The incretin concept today. Diabetologia 16: 75-87 (1979)
3. Fehmann, H. C., R. Göke, B. Göke: Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. Endocrine Reviews 16: 390-410 (1995)
4. Kolligs, F., H. C. Fehmann, R. Göke, B. Göke: Reduction of the incretin effect in rats by the glucagon-like peptide-I receptor antagonist exendin (9-39)amide. Diabetes 44: 16-19 (1995)
5. Mojsov, S., G. Heinrich, I. B. Wilson, M. Ravazzola, L. Orci, J. F. Habener: Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-transcriptional processing. J. Biol. Chem. 261: 11880-11889 (1986)
6. Schirra, J., M. Katschinski, C. Weidmann, R. Arnold, B. Göke: Gastric emptying and release of incretin hormones after glucose ingestion in humans. J. Clin. Invest. 97: 922-103 (1996)
7. Komatsu, R., T. Matsuyama, M. Namba, N. Watanabe, H. Itoh, N. Kono, S. Tarui: Glucagonostatic and insulinotropic action of glucagon-like peptide-I(7-36)amide. Diabetes 38: 902-905 (1989)
8. Fehmann, H. C., J. F. Habener: Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma βTC-1 cells. Endocrinology 130: 159-166 (1992)
9. Fehmann, H. C., J. F. Habener: Functional receptors for the insulinotropic hormone glucagon-like peptide-I(7-37) on a somatostatin secreting cell line. FEBS-Lett. 279: 335-340 (1991)
10. Fehmann, H. C., M. Janßen, B. Göke: Interaction of glucagon-like peptide-I(GLP-I) and galanin in insulin (βTC-1)-and somatostatin (RIN T3)-secretion cells and evidence that both peptides have no receptors on glucagon (INR1 G9)-secreting cells. Acta Diab. 32: 176-181 (1995)
11. Nauck, M. A., F. Stöckmann, R. Ebert, W. Creutzfeldt: Reduced incretin effect in type 2 (noninsulin-dependent) diabetes. Diabetologia 29: 46-52 (1986)
12. Orskov, C., J. Jeppesen, S. Madsbad, J. J. Holst: Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine. J. Clin. Invest. 87: 415-423 (1991)
13. Gutniak, M., C. Orskov, J. J. Holst, R. Ebert, W. Creutzfeldt: Antidiabetogenic effect of glucagon-like peptide-I(7-36)-amide in normal subjects and in patients with diabetes mellitus. New. Engl. J. Med. 326: 1316-1322 (1992)
14. Nauck, M. A., M. M. Heimesaat, C. Orskov, J. J. Holst, R. Ebert, W. Creutzfeldt: Preserved incretin activity of glucagon-like peptide-I (GLP-I) (7-36)-amide but not of synthetic human gastric inhibitory polypeptide (GIP) in patients with type 2 diabetes mellitus. J. Clin. Invest. 30: 301-307 (1993)
15. Zhang, Y., R. Proenca, M. Maffei, M. Barone, L. Leopold, J. M. Friedman: Positional cloning on the mouse obese gene and its human homologue. Nature (Lond.) 372: 425-431 (1994)
16. Halaas, J. L., K. S. Gajiwala, M. Maffei, S. L. Cohen, B. T. Chait, D. Rabinowifz, R. L. Lalone, S. K. Burley, J. M. Friedman: Weight reducing effects of the plasma protein encoded by the obese gene. Science 269: 543-546 (1995)
17. Pelleymounter, M. A., M. J. Cullen, M. B. Baker, R. Hecht, D. Winters, T. Boone, F. Collins: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 541-543 (1995)
18. Stephens, T. W., M. Basinski, W. K. Bristow, J. M. Bue-Valleskey, S. G. Burgett, L. Craft, J. Hale, J. Hoffmann, H. M. Hsuing, A. Kriaicinuas, W. MacKellar, P. R. Rosteck Jr, B. Schoner, F. C. Tinsley, X. Y. Zhang, M. Helman: The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature (Lond.) 377: 530-532 (1995)
19. Seeley, R. J., G. van Dijk, L. A. Campfield, F. J. Smith, P. Burn, J. A. Nelligan, S. M. Bell, D. G. Baskin, S. C. Woods, M. W. Schwartz: Intraventricular leptin reduces food intake and body weight of lean rats but not obese Zucker rats. Horm. Metab. Res. 28: 664-668 (1996)
20. Campfield, L. A., F. J. Smith, P. Burn: The OB protein (leptin) pathway - a link between adipose tissue mass and central neural networks. Horm. Metab. Res. 28: 619-632 (1996)
21. Tartaglia, L. A., M. Dembski, X. Weng, N. Deng, J. Culpepper, R. Devos, G. J. Richards, L. A. Campfield, F. T. Clark, J. Deeds, C. Muir, S. Sanker, A. Moriarty, K. J. Moore, J. S. Smutko, G. G. Mays, E. A. Woolf, C. A. Monroe, R. I. Tepper: Identification and expression cloning of a leptin receptor, OB-R. Cell 83: 1263-1271 (1995)
22. Chen, H., O. Charlat, A. Tartaglia, E. A. Woolf, X. Weng, S. J. Ellis, N. D. Lakey, J. Culpeper, K. J. Moore, R. E. Breitbart, G.M. Duyk, R. I. Tepper, J. P. Morgenstern: Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84: 491-495 (1996)
23. Malik, K. F., W. S. Young III: Localization of binding sites in the central nervous system for leptin (OB protein) in normal, obese (ob/ ob), and diabetic (db/db) C57 BL/6 J mice. Endocrinology 137: 1497-1500 (1996)
24. Muzzin, P., R. C. Eisensmith, K. C. Copeland, S. L. C. Woo: Correction of obesity and diabetes in genetically obese mice by leptin gene therapy. Proc. Natl. Acad. Sci. USA 93: 14804-14808 (1996)
25. Schwartz, M. W., D. G. Baskin, T. R. Bukowski, J. L. Kuiper, D. Foster, G. Lasser, D. E. Prunkhard, D. Porte Jr, S. C. Woods, R. J. Seeley, D. S. Weigle: Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 45: 531-535 (1996)
26. Hwa, J. J., L. Ghibaudi, D. Compton, A. B. Fawzi, C. D. Strader: Intracerebroventricular injection of leptin increases thermogenesis and mobilized fat metabolism in ob/ob mice. Horm. Metab. Res. 28: 659-663 (1996)
27. Kieffer, T. J., R. S. Heller, H. J. Habener: Leptin receptors expressed on pancreatic β-cells. Biochem. Biophys. Res. Comm. 224: 522-527 (1996)
28. Emilsson, V., Y. L. Liu, M. A. Cawthorne, M. M. Morton, M. Davenport: Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leption on insulin secretion: Diabetes 46: 313-316 (1997)
29. Fehmann, H. C, C. Peiser, H. P. Bode, M. Stamm, P. Staats, C. Hedetoft, R. E. Lang, B. Göke: Leptin: a potent inhibitor of insulin secretion. Peptides (in press)
30. Fehmann, H. C., P. Berghöfer, D. Brandhorst, H. Brandhorst, R. G. Bretzel, G. Göke: Leptin inhibition of glucose-induced insulin secretion from isolated human islets. Acta Diabetologia (in press)
31. Asfari, M., D. Janjic, P. Meda, G. Li, P. A. Halban, C. B. Wollheim: Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 130: 167-178 (1992)
32. Grodsky, G. M., A. A. Batts, L. I. Bennett, C. Vcella, N. D. McWilliams, D. F. Smith: Effects of carbohydrates on secretion of insulin from isolated perfused rat pancreas. Am. J. Physiol. 205: 638-639 (1963)
33. Bode, H. P., B. Göke: Protein kinase C activated capacitative calcium entry in the insulin secretion cell line RINm5F. FEBS-Lett. 339: 307-311 (1994)
34. Cohen, B., D. Novick, M. Rubinstein: Modulation of insulin activities by leptin. Science 274: 1185-1188 (1996)
35. Göke, B., R. Göke, H. C. Fehmann, H. P. Bode: Physiology and pathophysiology of GLP-I. In: Lefevre, P. J., (ed.). Glucagon III, (Handbook of Experimental Pharmacology). Springer, Berlin-Heidelberg 1996, pp 275-309
36. 2+ channel activity. Endocrinology 133: 1685-1692 (1993)
37. 2+ signaling pathways in pancreatic β-cells by the insulinotropic hormone glucagon-like peptide-I. J. Biol. Chem. 270: 17749-17757 (1995)